Thomas Pogge Quotes About Innovation

• It is irrational to charge high prices for socially valuable innovations as this guarantees that they will be underutilized. It is much better to sell them at cost and then to reward the innovator in some other way. This is not always possible, because in some cases the value of an innovation is in the eye of the beholder; it's very difficult to value how much a new Madonna song is worth, for example. But in the case of medicines, green technologies and seeds in agriculture, such an alternative reward mechanism is fairly straightforward.

  Thomas Pogge

  Song, Eye, Technology

  Fuente: www.truth-out.org

• If you ask yourself who is paying for pharmaceutical innovation today, the answer is that it's the more affluent populations paying for still-patented advanced medicines at the pharmacy, for comprehensive insurance coverage or for a national health system.

  Thomas Pogge

  Medicine, Innovation, Population

  Fuente: www.truth-out.org

• For the present system to work, poor people must be excluded from the innovation, because if they could get access at an affordable price, then affluent people would find ways to buy it cheaply as well - and then the innovator would be poorly rewarded and introductions of new medicines would decline.

  Thomas Pogge

  Medicine, People, Innovation

  Fuente: www.truth-out.org

• Con el Fondo de Impacto Sanitario, la innovación se paga aparte, mediante recompensas de impacto sanitario financiadas con fondos públicos, y el producto se vende al coste de producción para todos. En este caso, ya no sería necesaria la cruel injusticia de impedir que los pobres compren a precio de coste, como demuestra la supresión actual del comercio de versiones genéricas de medicamentos patentados.

  Thomas Pogge

  Impact, Medicine, Innovation

  Fuente: www.truth-out.org

• You can think of the Health Impact Fund as a mechanism that would keep the benefits and burdens of pharmaceutical innovation for the affluent roughly as they are while massively reducing the burdens presently imposed upon the poor. This sounds like magic. But it really works because the current system is not Pareto efficient. It's a system that generates hundreds of billions of dollars in litigation costs and deadweight losses that HIF-registered medicines would sidestep. By avoiding these losses, the HIF reform can bring improvements all around - including for pharmaceutical innovators.

  Thomas Pogge

  Loss, Thinking, Medicine

  Fuente: www.truth-out.org

• Tenemos este sistema altamente irracional de incentivar la innovación para las tecnologías limpias y ecológicas, en el que permitimos que el innovador tenga un monopolio temporal y luego subimos el precio del producto o vendemos licencias a precios elevados a quienes quieren utilizar el tipo de producto que el innovador ha inventado. Este sistema es colectivamente irracional porque muchas personas, para evitar los precios inflados de las tecnologías más limpias y ecológicas aún patentadas, optan por alguna tecnología más antigua que es mucho más contaminante.

  Thomas Pogge

  Technology, People, Innovation

  Fuente: www.truth-out.org

• What we should do is require or at least permit innovators to license their green innovations free of charge in exchange for public payments based on the impact this innovation has on the environment - emissions averted or something of this sort.

  Thomas Pogge

  Impact, Innovation, Green

  Fuente: www.truth-out.org

También te puede gustar:

John Rawls

Martha C. Nussbaum

Thomas Nagel

Robert Nozick

Jeffrey Sachs

Immanuel Kant

Joseph Stiglitz